Subcutaneous Drug Delivery Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Subcutaneous Drug Delivery Market covers analysis By Product Type (Fillable Injectable, Prefilled Injectable) ; Type (Disposable subcutaneous drug delivery injectable, Reusable subcutaneous drug delivery injectable) ; Technology type (Jet, Spring, Gas) ; Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug store, Online Pharmacies), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00008633
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering medications such as insulin, morphine, diacetylmorphine and goserelin.

MARKET DYNAMICS



The subcutaneous drug delivery market in robust R&D activities is resulting from an increasing number of pipeline products, which may drive the growth of the global subcutaneous drug delivery market. However, the rise in awareness about the presence of subcutaneous drug deliverys has lowered ignorance toward venom-bites, which is restraining the market growth. Moreover, presence of large population density in countries such as China, India and Brazil, where there is high prevalence of bacterial diseases, favorable reimbursement scenario for treatments and medications, is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE



The "Subcutaneous Drug Delivery Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of in subcutaneous drug delivery market with detailed market segmentation by technology type, type, product type, distribution channel and geography. The subcutaneous drug delivery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in subcutaneous drug delivery market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The subcutaneous drug delivery market is segmented on the basis of product type, type, and technology type and distribution channel. Based on product type the market is segmented as fillable injectable and prefilled injectable. On the basis of type the market is categorized as disposable subcutaneous drug delivery injectable and reusable subcutaneous drug delivery injectable. On the basis of technology type the market is categorized as jet, spring and gas. Based on the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies, drug store and online pharmacies.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in subcutaneous drug delivery market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The subcutaneous drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting subcutaneous drug delivery market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the subcutaneous drug delivery market in these regions.


MARKET PLAYERS



The report covers key developments in the in subcutaneous drug delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in subcutaneous drug delivery market are anticipated to have lucrative growth opportunities in the future with the rising demand for in subcutaneous drug delivery market in the global market. Below mentioned is the list of few companies engaged in the subcutaneous drug delivery market.

The report also includes the profiles of key in subcutaneous drug delivery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Amgen Inc
- Becton, Dickinson and Company
- Consort Medical plc.
- Elcam Medical
- F. Hoffmann-La Roche AG
- Genentech, Inc.
- scPharmaceuticals, Inc.
- Sensile Medical AG
- West Pharmaceutical Services, Inc.
- Ypsomed AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Subcutaneous Drug Delivery Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Fillable Injectable
  • Prefilled Injectable
By Type
  • Disposable subcutaneous drug delivery injectable
  • Reusable subcutaneous drug delivery injectable
By Technology type
  • Jet
  • Spring
  • Gas
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug store
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen Inc
  • Becton, Dickinson and Company
  • Consort Medical plc.
  • Elcam Medical
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • scPharmaceuticals, Inc.
  • Sensile Medical AG
  • West Pharmaceutical Services, Inc.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Amgen Inc
    2. Becton, Dickinson and Company
    3. Consort Medical plc.
    4. Elcam Medical
    5. F. Hoffmann-La Roche AG
    6. Genentech, Inc.
    7. scPharmaceuticals, Inc.
    8. Sensile Medical AG
    9. West Pharmaceutical Services, Inc.
    10. Ypsomed AG

    Buy Now